AbbVie Inc.

US · LEI FR5LCKFTG8054YNNRU85 · Figures of the company

AbbVie Inc.: 44 links from the documents of the companies and the register.

Lenders 20

Entity	Figure	Evidence	Documents
Banco Santander, S.A., New York Branch	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Bank of America, N.A.	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Barclays Bank PLC	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Citibank, N.A.	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Credit Suisse AG, Cayman Islands Branch	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Deutsche Bank AG New York Branch	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
DNB Capital LLC	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
(g) As of the Pre-Closing Funding Date or the Closing Date	Named as a lender under 1 agreement	Stated	364-Day Bridge Credit Agreement of 25 June 2019
Goldman Sachs Bank USA	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
HSBC Bank USA, National Association, as a	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
JPMorgan Chase Bank, N.A.	Named as a lender under 1 agreement	Stated	Form 10-K for the fiscal year ended 31 December 2025 Amended and Restated Revolving Credit Agreement of 27 August 2019
Lloyds Bank Corporate Markets plc	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Mizuho Bank, Ltd.	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Morgan Stanley Bank, N.A.	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Morgan Stanley Senior Funding, Inc.	Named as a lender under 2 agreements	Stated	364-Day Bridge Credit Agreement of 25 June 2019 Amended and Restated Revolving Credit Agreement of 27 August 2019
MUFG Bank, Ltd.	Named as a lender under 2 agreements	Stated	364-Day Bridge Credit Agreement of 25 June 2019 Amended and Restated Revolving Credit Agreement of 27 August 2019
Royal Bank of Canada	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
The Northern Trust Company	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
U.S. Bank National Association	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019
Wells Fargo Bank, National Association	Named as a lender under 1 agreement	Stated	Amended and Restated Revolving Credit Agreement of 27 August 2019

Holdings 19

Entity	Figure	Evidence	Documents
AbbVie Biopharmaceuticals GmbH	Consolidates the entity	Register	Record of AbbVie Biopharmaceuticals GmbH in the register of legal entities, 4 November 2026
Abbvie Biotechnology Ltd.	Consolidates the entity	Register	Record of ABBVIE BIOTECHNOLOGY LTD in the register of legal entities, 4 November 2026
AbbVie Central Finance B.V.	Consolidates the entity	Register	Record of AbbVie Central Finance B.V. in the register of legal entities, 4 November 2026
AbbVie Corporation	Consolidates the entity	Register	Record of AbbVie Corporation in the register of legal entities, 4 November 2026
AbbVie Enterprises B.V.	Consolidates the entity	Register	Record of AbbVie Enterprises B.V. in the register of legal entities, 4 November 2026
Abbvie Farmaceutica Ltda.	Consolidates the entity	Register	Record of Abbvie Farmaceutica Ltda. in the register of legal entities, 4 November 2026
Abbvie Farmaceuticos SA de CV	Consolidates the entity	Register	Record of ABBVIE FARMACEUTICOS SA DE CV in the register of legal entities, 4 November 2026
AbbVie Finance B.V.	Consolidates the entity	Register	Record of AbbVie Finance B.V. in the register of legal entities, 4 November 2026
AbbVie GK	Consolidates the entity	Register	Record of AbbVie GK in the register of legal entities, 4 November 2026
AbbVie GmbH	Consolidates the entity	Register	Record of AbbVie GmbH in the register of legal entities, 4 November 2026
AbbVie Logistics B.V.	Consolidates the entity	Register	Record of AbbVie Logistics B.V. in the register of legal entities, 4 November 2026
Abbvie Ltd.	Consolidates the entity	Register	Record of ABBVIE LTD in the register of legal entities, 4 November 2026
Abbvie Manufacturing Management Unlimited Company	Consolidates the entity	Register	Record of ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY in the register of legal entities, 4 November 2026
AbbVie Pharmaceuticals (Thailand) Ltd.	Consolidates the entity	Register	Record of AbbVie Pharmaceuticals (Thailand) Ltd. in the register of legal entities, 4 November 2026
Abbvie PTE. Ltd.	Consolidates the entity	Register	Record of ABBVIE PTE. LTD. in the register of legal entities, 4 November 2026
Abbvie Pty Ltd.	Consolidates the entity	Register	Record of ABBVIE PTY LTD in the register of legal entities, 4 November 2026
Allergan Pharmaceuticals Ireland Unlimited Company	Consolidates the entity	Register	Record of Allergan Pharmaceuticals Ireland Unlimited Company in the register of legal entities, 4 November 2026
Aptalis Pharma Canada ULC	Consolidates the entity	Register	Record of Aptalis Pharma Canada ULC in the register of legal entities, 4 November 2026
Pharmacyclics Switzerland GmbH	Consolidates the entity	Register	Record of Pharmacyclics Switzerland GmbH in the register of legal entities, 4 November 2026

Partners 5

Entity	Figure	Evidence	Documents
ADARx Pharmaceuticals, Inc.	Named as a collaboration partner	Stated	Form 10-K for the fiscal year ended 31 December 2025
Genentech, Inc.	Named as a collaboration partner	Stated	Form 10-K for the fiscal year ended 31 December 2025
Gubra A/S	Named as a collaboration partner	Stated	Form 10-K for the fiscal year ended 31 December 2025
Ichnos Glenmark Innovation, Inc.	Named as a collaboration partner	Stated	Form 10-K for the fiscal year ended 31 December 2025
Janssen Biotech, Inc	Named as a collaboration partner	Stated	Form 10-K for the fiscal year ended 31 December 2025

Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.